Company Filing History:
2 out of 9 
1 out of 1,209 
Years Active: 2025
Title: Daekwon Kim: Innovator in Pharmaceutical Chemistry
Introduction
Daekwon Kim is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target protein kinase-related diseases. His work is crucial in advancing treatments for various health conditions, including cancer.
Latest Patents
Daekwon Kim holds a patent for a pyrrolopyridine derivative, which is utilized in the prevention and treatment of protein kinase-related diseases. The patent describes a pharmaceutical composition that includes this derivative as an active ingredient. This compound demonstrates excellent inhibitory activity against several protein kinases, including LRRK2, DYRK1, and CLK1. It has shown promising results in suppressing the growth of triple-negative breast cancer cells. The pharmaceutical composition can be effectively used to treat or prevent various diseases, including cancers, degenerative brain diseases, and inflammatory conditions.
Career Highlights
Daekwon Kim is currently associated with Voronoi Inc., where he continues to innovate in the pharmaceutical sector. His research focuses on developing effective treatments for serious health issues, leveraging his expertise in medicinal chemistry.
Collaborations
He collaborates with talented colleagues, including Myungho Jung and Jungyeon Yun, to further enhance the impact of his research and inventions.
Conclusion
Daekwon Kim's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes in the treatment of serious diseases.